B01 RFI Sources Sought.doc
DOC document 33 KB Posted
- Solicitation number
- HT9425JF3779
- Issued by
-
Defense Health Agency
About this file
This Request for Information (RFI)/Sources Sought Notice outlines requirements for procurement support, clinical and epidemiological services, purchase of supplies and equipment, transportation, communications and administrative support in Cambodia and neighboring countries. The Armed Forces Research Institute Medical Sciences and US Army Medical Research Acquisition Activity are seeking these services to support projects involving surveillance for emerging infectious diseases and conducting clinical trials within Cambodia. Pathogens of interest include respiratory viruses, leptospirosis, bacterial pathogens, and agents of parasitic disease such as malaria. Potential clinical trial products mentioned are anti-malarial drugs and vaccines, anti-viral drugs, and anti-microbial drugs. Vendors must be able to provide office space, utilities, and security in Cambodia per US Embassy regulations. Responses are due by March 30, 2023 for market research and planning purposes only. No contract will be awarded from this announcement.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
This Request for Information (RFI)/Sources Sought (SS) Notice is for market research, information and planning purposes only and shall not be construed as a solicitation or as an obligation on the part of the Armed Forces Research Institute Medical Sciences (AFRIMS) or the US Army Medical Research Acquisition Activity (USAMRAA). The purpose of this requirement procurement support, clinical and epidemiological services, purchase of supplies and equipment, transportation, communications and administrative support in Cambodia and neighboring countries. This requirement will provide scientific, technical and administrative services for AFRIMS projects involving surveillance for emerging infectious diseases and conducting clinical trials within Cambodia. Pathogens that may be the subject of surveillance studies include respiratory viral pathogens, leptospirosis, bacterial pathogens, agents of parasitic disease including malaria, and other emerging infections. Products that may be evaluated in clinical trials include anti-malarial drugs and/or vaccines, anti-viral drugs, anti-microbial drugs, and other potential candidates with activity against infectious disease agents. In addition, the contractor must provide office space, utilities, as well as security per the regulations of the United States Embassy Security Office. The Vendor must be able to work within the host country (Cambodia). This announcement is not a formal solicitation and is not a request for proposal. No contract will be awarded from this announcement. No reimbursement will be made of any costs to provide information in response to this announcement or any follow up information requests. Availability of any formal solicitation will be announced under a separate announcement. This synopsis is for market research, information and planning purposes only and is not to be construed as a commitment by the Government. Each response must reference the sources sought title. All proprietary information should be marked as such. Responses will be held confidential if requested. Please submit fact sheets/capability Statements may be emailed to: john.l.fitzsimmons8.civ@health.mil. Responses must be received no later than 30 March 2023.
File details come from the government source that posted it. Updated .